O-119: A Multimarker Panel Predicts Complete Response after Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma

Aims: Achievement of a complete response (CR) after transarterial chemoembolization (TACE) is the most robust predictor of favorable outcomes in patients with hepatocellular carcinoma (HCC). The aim of this study was to identify blood-based biomarkers to predict a sustained CR after TACE using targeted proteomics. Methods: Consecutive patients with HCC who had undergone TACE were drawn from our prospective cohort [training set (n=100) and...